Kenya Bio-Vax Institute (KBVI) - BETA - 2024 |
|
|---|---|
|
State Department |
|
|
Programme |
|
|
Sub Programme |
|
|
Allocation: |
KES 281,500,000.00 (R) |
Key Performance Indicators (Targets)
Key Output |
KPI |
Target Yr (2024) |
Target Yr (2025) |
Target Yr (2026) |
|---|---|---|---|---|
Vaccine Production Services |
Percentage completion rate of human vaccine fill-and-finish facility |
60 |
70 |
90 |
Vaccine Production Services |
No. of products manufactured |
- |
- |
1 |
Vaccine Production Services |
Percentage completion rate of Research & Development centre |
10 |
15 |
20 |
Vaccine Production Services |
Number of HPTs technology transfer agreements |
1 |
1 |
1 |
Vaccine Production Services |
Number of personnel trained in administrative and specialized HPTs manufacturing |
50 |
60 |
70 |
Vaccine Production Services |
Number of specialty staff recruited |
20 |
20 |
20 |
Vaccine Production Services |
Percentage completion rate of quality management systems established |
75 |
85 |
95 |
Vaccine Production Services |
Number of partnerships and collaborations |
3 |
3 |
3 |
Vaccine Production Services
Percentage completion rate of human vaccine fill-and-finish facility
2024
60
2025
70
2026
90
Vaccine Production Services
No. of products manufactured
2024
-
2025
-
2026
1
Vaccine Production Services
Percentage completion rate of Research & Development centre
2024
10
2025
15
2026
20
Vaccine Production Services
Number of HPTs technology transfer agreements
2024
1
2025
1
2026
1
Vaccine Production Services
Number of personnel trained in administrative and specialized HPTs manufacturing
2024
50
2025
60
2026
70
Vaccine Production Services
Number of specialty staff recruited
2024
20
2025
20
2026
20
Vaccine Production Services
Percentage completion rate of quality management systems established
2024
75
2025
85
2026
95
Vaccine Production Services
Number of partnerships and collaborations
2024
3
2025
3
2026
3
Previous Year Allocations
User Uploads
Proportion of shared services on boarded onto the Digital Health Agency.: 25
KES 352,000,000.00
KES 180,000,000.00
(2024)
Number of Research evidence briefs developed: 17
KES 500,000,000.00
KES 400,000,000.00
(2024)
Number of New research protocols approved: 200
KES 2,508,950,000.00
(2024)